84.62
price down icon0.20%   -0.17
after-market After Hours: 84.62
loading
Prestige Consumer Healthcare Inc stock is traded at $84.62, with a volume of 283.55K. It is down -0.20% in the last 24 hours and up +1.98% over the past month. Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
See More
Previous Close:
$84.79
Open:
$84.79
24h Volume:
283.55K
Relative Volume:
0.76
Market Cap:
$4.18B
Revenue:
$1.11B
Net Income/Loss:
$205.95M
P/E Ratio:
20.59
EPS:
4.11
Net Cash Flow:
$254.64M
1W Performance:
+0.17%
1M Performance:
+1.98%
6M Performance:
-1.24%
1Y Performance:
+30.55%
1-Day Range:
Value
$84.08
$84.98
1-Week Range:
Value
$84.08
$86.19
52-Week Range:
Value
$63.79
$90.04

Prestige Consumer Healthcare Inc Stock (PBH) Company Profile

Name
Name
Prestige Consumer Healthcare Inc
Name
Phone
(914) 524-6800
Name
Address
660 WHITE PLAINS RD., TARRYTOWN, NY
Name
Employee
600
Name
Twitter
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
PBH's Discussions on Twitter

Compare PBH with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
PBH
Prestige Consumer Healthcare Inc
84.62 4.17B 1.11B 205.95M 254.64M 4.11
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
11.12 50.98B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
168.61 74.41B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
RDHL
Redhill Biopharma Ltd Adr
1.93 4.03M 35.75M 11.57M -26.25M -3.8069
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.99 46.23B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
17.25 20.10B 16.54B -1.64B 749.00M -1.45

Prestige Consumer Healthcare Inc Stock (PBH) Upgrades & Downgrades

Date Action Analyst Rating Change
Dec-09-24 Downgrade Sidoti Buy → Neutral
Jun-21-24 Upgrade DA Davidson Neutral → Buy
Nov-17-22 Initiated Canaccord Genuity Buy
May-10-22 Upgrade Jefferies Hold → Buy
May-09-22 Upgrade Oppenheimer Perform → Outperform
Aug-07-20 Downgrade DA Davidson Buy → Neutral
Jun-29-20 Upgrade Sidoti Neutral → Buy
Apr-14-20 Downgrade Jefferies Buy → Hold
Apr-07-20 Resumed Sidoti Neutral
Mar-26-20 Upgrade Jefferies Hold → Buy
Mar-24-20 Initiated Oppenheimer Perform
Mar-19-20 Upgrade DA Davidson Neutral → Buy
Jan-15-19 Downgrade Raymond James Outperform → Mkt Perform
Dec-04-17 Upgrade William Blair Mkt Perform → Outperform
Jun-02-17 Upgrade Jefferies Underperform → Hold
May-22-17 Upgrade Raymond James Mkt Perform → Outperform
Dec-27-16 Reiterated B. Riley & Co. Buy
Nov-17-16 Initiated Gabelli & Co Buy
Aug-12-16 Upgrade Sidoti Neutral → Buy
Mar-08-16 Initiated KeyBanc Capital Mkts Overweight
Feb-05-16 Initiated Piper Jaffray Overweight
Nov-30-15 Downgrade Jefferies Hold → Underperform
Apr-28-14 Reiterated B. Riley & Co. Buy
Apr-28-14 Reiterated Oppenheimer Outperform
Jul-09-13 Initiated B. Riley & Co. Buy
View All

Prestige Consumer Healthcare Inc Stock (PBH) Latest News

pulisher
Jun 03, 2025

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick - Yahoo Finance

Jun 03, 2025
pulisher
Jun 02, 2025

Zacks Research Issues Optimistic Outlook for PBH Earnings - Defense World

Jun 02, 2025
pulisher
Jun 01, 2025

Tidal Investments LLC Sells 1,380 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) - Defense World

Jun 01, 2025
pulisher
May 31, 2025

Equities Analysts Set Expectations for PBH Q1 Earnings - Defense World

May 31, 2025
pulisher
May 29, 2025

Cetera Investment Advisers Invests $413,000 in Prestige Consumer Healthcare Inc. (NYSE:PBH) - Defense World

May 29, 2025
pulisher
May 29, 2025

The Sandlot Star Patrick Renna Teams Up with Dramamine® to Revisit an Iconic SceneThis Time, Puke Free - The Malaysian Reserve

May 29, 2025
pulisher
May 28, 2025

Lice Treatment Market Deep Research Report Identifies Key TrendsPrestige Consumer Healthcare, Reckitt - openPR.com

May 28, 2025
pulisher
May 27, 2025

Prestige Consumer Gains 35.7% in a Year: What's Driving the Stock? - Nasdaq

May 27, 2025
pulisher
May 26, 2025

Prestige Consumer Healthcare Inc. (NYSE:PBH) Holdings Decreased by Nuveen Asset Management LLC - Defense World

May 26, 2025
pulisher
May 21, 2025

Deutsche Bank AG Purchases 14,929 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) - Defense World

May 21, 2025
pulisher
May 21, 2025

Prestige Consumer Healthcare Inc. (NYSE:PBH) Position Reduced by Ameriprise Financial Inc. - Defense World

May 21, 2025
pulisher
May 17, 2025

Prestige Consumer Healthcare (NYSE:PBH) Upgraded to “Buy” at StockNews.com - Defense World

May 17, 2025
pulisher
May 16, 2025

Weekly Recap: 14 Health Press Releases You Need to See - Yahoo Finance

May 16, 2025
pulisher
May 15, 2025

Prestige's Diversified Portfolio and Strong Execution Should Drive Steady Growth Across Categories - Morningstar

May 15, 2025
pulisher
May 14, 2025

Prestige Consumer Stock Up 8% Since Q4 Earnings Beat, Margin Increase - MSN

May 14, 2025
pulisher
May 14, 2025

U.S. News Announces the 2025-2026 Best OTC Medicine & Health Products - Morningstar

May 14, 2025
pulisher
May 14, 2025

Prestige Consumer Healthcare Inc. (NYSE:PBH) Q4 2025 Earnings Call Transcript - Insider Monkey

May 14, 2025
pulisher
May 14, 2025

How To Trade (PBH) - news.stocktradersdaily.com

May 14, 2025
pulisher
May 12, 2025

Prestige Consumer Healthcare’s Earnings Call Highlights Growth Amid Challenges - TipRanks

May 12, 2025
pulisher
May 12, 2025

Aussie Stocks Hold Steady With US-China Trade Optimism - Finimize

May 12, 2025
pulisher
May 12, 2025

Prestige Consumer Healthcare (NYSE:PBH) Cut to “Hold” at StockNews.com - Defense World

May 12, 2025
pulisher
May 10, 2025

Prestige Consumer Healthcare Full Year 2025 Earnings: EPS Misses Expectations - Yahoo Finance

May 10, 2025
pulisher
May 10, 2025

Prestige Consumer Healthcare (NYSE:PBH) Stock Rating Upgraded by Royal Bank of Canada - Defense World

May 10, 2025
pulisher
May 10, 2025

Jefferies raises Prestige Brands target to $85, maintains Hold rating By Investing.com - Investing.com India

May 10, 2025
pulisher
May 10, 2025

Decoding Prestige Consumer Healthcare Inc (PBH): A Strategic SWO - GuruFocus

May 10, 2025
pulisher
May 09, 2025

Saline Nasal Spray Market to See Ongoing Evolution | Major Giants Pfizer Inc,Bayer AG,Novartis AG - newstrail.com

May 09, 2025
pulisher
May 09, 2025

Jefferies raises Prestige Brands target to $85, maintains Hold rating - Investing.com

May 09, 2025
pulisher
May 09, 2025

These 4 Measures Indicate That Prestige Consumer Healthcare (NYSE:PBH) Is Using Debt Reasonably Well - simplywall.st

May 09, 2025
pulisher
May 09, 2025

Prestige Consumer Healthcare Inc. SEC 10-K Report - TradingView

May 09, 2025
pulisher
May 09, 2025

Prestige Consumer Healthcare Reports Record Fiscal 2025 Results - TipRanks

May 09, 2025
pulisher
May 08, 2025

Prestige Consumer Healthcare: Fiscal Q4 Earnings Snapshot - Greenwich Time

May 08, 2025
pulisher
May 08, 2025

Prestige Consumer Healthcare Q4 2025 Earnings Call Transcript - MarketBeat

May 08, 2025
pulisher
May 08, 2025

Transcript : Prestige Consumer Healthcare Inc., Q4 2025 Earnings Call, May 08, 2025 - marketscreener.com

May 08, 2025
pulisher
May 08, 2025

Prestige: Diversified Portfolio and Strong Execution Drive Steady Growth Across Categories - Morningstar

May 08, 2025
pulisher
May 08, 2025

Premium Brands Holdings (PBH) Target Price Raised by Scotiabank - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Prestige Consumer Healthcare (PBH) Reports Q4 Earnings: What Key Metrics Have to Say - Yahoo Finance

May 08, 2025
pulisher
May 08, 2025

Prestige Consumer Healthcare to Seek M&A - marketscreener.com

May 08, 2025
pulisher
May 08, 2025

UPDATED: Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Revenue and Earnings | PBH Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Prestige Consumer Healthcare Inc. Q4 Profit Increases, Beats Estimates - Nasdaq

May 08, 2025
pulisher
May 08, 2025

Prestige Consumer Healthcare (PBH) Tops Q4 Earnings and Revenue Estimates - Yahoo Finance

May 08, 2025
pulisher
May 08, 2025

UPDATED: Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Revenue and Earnings - Bluefield Daily Telegraph

May 08, 2025
pulisher
May 08, 2025

Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Rev - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Prestige Consumer (PBH) Reports Strong Q4 Revenue and Earnings Growth | PBH Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Prestige Consumer Healthcare Reports Record Fiscal Year Revenue - TipRanks

May 08, 2025
pulisher
May 08, 2025

Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Revenue and Earnings - The Manila Times

May 08, 2025
pulisher
May 08, 2025

Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Revenue and Earnings | PBH Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Earnings Flash (PBH) Prestige Consumer Healthcare Posts Q4 Revenue $296.5M, vs. FactSet Est of $291.1M - marketscreener.com

May 08, 2025

Prestige Consumer Healthcare Inc Stock (PBH) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$8.46
price down icon 1.51%
$124.61
price up icon 0.07%
drug_manufacturers_specialty_generic RDY
$15.53
price up icon 5.29%
drug_manufacturers_specialty_generic HCM
$15.26
price down icon 0.26%
$319.71
price down icon 1.31%
$17.25
price down icon 1.54%
Cap:     |  Volume (24h):